Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI)

Parametric mapping techniques provide a non-invasive tool for quantifying tissue alterations in myocardial disease in those eligible for cardiovascular magnetic resonance (CMR). Parametric mapping with CMR now permits the routine spatial visualization and quantification of changes in myocardial composition based on changes in T1, T2, and T2*(star) relaxation times and extracellular volume (ECV). These changes include specific disease pathways related to mainly intracellular disturbances of the cardiomyocyte (e.g., iron overload, or glycosphingolipid accumulation in Anderson-Fabry disease); extracellular disturbances in the myocardial interstitium (e.g., myocardial fibrosis or cardiac amyloidosis from…

• UO
  University of Pittsburgh
• MU
  McGill University
• DZ
  Deutsches Zentrum für Herz-Kreislaufforschung
• UO
  University of Alberta
• UC
  University College London
• UO
  University of Oxford
• UO
  University of Toronto
• KI
  Karolinska Institutet
• UD
  Université de Montréal
• HF
  Hospital for Sick Children
• UD
  Université de Lausanne
• CH
  Centre Hospitalier Universitaire Vaudois
• BH
  Baker Heart and Diabetes Institute
• NI
  National Institutes of Health
• CA
  Clinical and Translational Science Institute, University of Pittsburgh